SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines	DNA Virus Infections, Infections, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Tumor Virus Infections, adenocarcinoma, carcinoma, cutaneous neuroendocrine carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, polyomavirus infectious disease, primitive neuroectodermal tumor, viral infectious disease	Active, not recruiting	Not applicable	2026-06-12		NCT04705389

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
European Wellness Academy	2
University Hospital, Tours	82

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Academic Hospital of Maastricht	Maastricht	Netherlands	1
Department of Dermatology, Başkent University Faculty of Medicine	Ankara	Turkey (Türkiye)	1
Department of Dermatology, Carol Davila University of Medicine and Pharmacy	Bucharest	Romania	1
Department of Dermatology, Medical University of Vienna	Vienna	Austria	1
Dermatology Dept, Hospital University of Tours	Tours	France	1
National Tumour Institute "Fondazione G. Pascale" Unit of Melanoma - Cancer Immunotherapy and Innovative therapy	Naples	Italy	1
Queen Elizabeth Hospital	Birmingham	United Kingdom	23
Skin Cancer and Surgery Center, Sahlgrenska University Hospital	Gothenburg	Sweden	1
Translational Skin Cancer Research	Essen	Germany	1
University Hospital of Helsinki, Finland	Helsinki	Finland	1